NBX-002

N/A

Report date: 2025/01/26 17:22:54

Base Information

Drug NameNBX-002
Drug Alias NameNBX-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionLeukocyte elastase inhibitors
TargetsLeukocyte elastase
Therapy Area/IndicationsLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTiumBio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTiumBio Co Ltd
Inactive CompaniesN/A
Active IndicationsLung Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A